NCT02561897View on ClinicalTrials.gov

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

PHASE4TerminatedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2017

Conditions

Atrial Fibrillation

Interventions

DRUG

Edoxaban

DRUG

Warfarin

Trial Locations (1)

07059

Electrophysiology Research Foundation, Warren Township

Sponsors

Collaborators (1)

Axio Research Corporation

All Listed Sponsors

collaborator

Axio Research Corporation

INDUSTRY

lead

Electrophysiology Research Foundation

OTHER